Progesterone and Kalbitor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Progesterone (progesterone) and Kalbitor (ecallantide). Common drug interactions include hereditary angioedema among females and laryngeal oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Progesterone and Kalbitor. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Progesterone?

Progesterone has active ingredients of progesterone. It is often used in menopause. eHealthMe is studying from 21,021 Progesterone users. Check the latest studies of Progesterone.

What is Kalbitor?

Kalbitor has active ingredients of ecallantide. eHealthMe is studying from 2,079 Kalbitor users. Check the latest studies of Kalbitor.



On Jul, 05, 2026

24 people who take Progesterone and Kalbitor together, and have interactions are studied.

Progesterone and Kalbitor drug interactions.

What are the common drug interactions of Progesterone and Kalbitor, by gender? *:

female:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Headache (pain in head)
  3. Abdominal pain
  4. Anaphylactic reaction (serious allergic reaction)
  5. Back pain
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Dizziness
  8. Drug ineffective
  9. Impaired healing
  10. Joint injury

male:

  1. Laryngeal oedema (swelling of larynx)

What are the common drug interactions of Progesterone and Kalbitor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Disturbance in attention
  3. Fatigue (feeling of tiredness)
  4. Limb injury
  5. Rash
  6. Agitation (state of anxiety or nervous excitement)
  7. Anaphylactic reaction (serious allergic reaction)
  8. Chest discomfort
  9. Discomfort
  10. Drug ineffective

20-29:

  1. Disturbance in attention
  2. Fatigue (feeling of tiredness)
  3. Hereditary angioedema (recurrent episodes of severe swelling)
  4. Limb injury
  5. Rash
  6. Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

  1. Road traffic accident
  2. Abdominal pain
  3. Pain
  4. Sensory disturbance (sense disturbance)
  5. Stress
  6. Swelling
  7. Tendonitis (a condition that causes pain and swelling of tendons)
  8. Sinusitis (inflammation of sinus)
  9. Upper respiratory tract infection
  10. Blood pressure decreased

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Hereditary Angioedema (recurrent episodes of severe swelling): 20 people, 83.33%
  2. Immune System Disorder: 5 people, 20.83%
  3. Hypersensitivity: 5 people, 20.83%
  4. Asthma: 5 people, 20.83%
  5. High Blood Cholesterol: 3 people, 12.50%
  6. Dizziness: 3 people, 12.50%
  7. Thyroid Diseases: 2 people, 8.33%
  8. Immune Tolerance Induction: 2 people, 8.33%
  9. Birth Control: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Progesterone and Kalbitor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Progesterone and Kalbitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Progesterone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kalbitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Progesterone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kalbitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on progesterone and ecallantide (the active ingredients of Progesterone and Kalbitor, respectively), and Progesterone and Kalbitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: